申请人:Bayer Aktiengesellschaft
公开号:US04179500A1
公开(公告)日:1979-12-18
The invention concerns the provision of novel 1,4-dihydropyridine-sugar derivatives and processes for their preparation. The invention also concerns pharmaceutical compositions containing the compounds of the invention and methods for their use. The products of the invention, such as 2-[1,4-dihydro-5-(2-propyl)-oxycarbonyl-2,6-dimethyl-4-m-nitrophenyl-3- pyridylcarbonyloxy]-ethyl .beta.-D-glucopyranoside, are effective for the treatment of circulatory disorders and can be used as antihypertensive agents, vasodilators or coronary therapeutic agents.
本发明涉及提供新型1,4-二氢吡啶-糖衍生物及其制备方法。本发明还涉及包含本发明化合物的制药组合物和使用方法。本发明的产物,如2-[1,4-二氢-5-(2-丙基)-氧羰基-2,6-二甲基-4-对硝基苯基-3-吡啶基羰基氧基]-乙基-β-D-葡萄糖苷,对于治疗循环障碍是有效的,可用作降压剂、扩血管剂或冠脉治疗剂。